Investigators are developing a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using engineered stem cells that may eventually lead to personalized treatments.
Click here for original story, Engineering the next generation of cell and gene therapies
Source: ScienceDaily